OTC Pharmaceuticals - Americas

Americas

In 2024, the revenue in the OTC Pharmaceuticals market in the Americas amounts to a staggering US$61.02bn.
This market is expected to experience an annual growth rate of (CAGR 2024-2029).
The largest market within this market is the Cold & Cough Remedies market, which is projected to reach a volume of US$14.33bn in 2024.
When compared globally, the in the United States generates the highest revenue, reaching US$41,240.00m in 2024.
This showcases the significant market presence of the US in the OTC Pharmaceuticals market industry.
Taking into account the total population figures, the per person revenue in the Americas is estimated to be US$60.01 in 2024.
This indicates the level of spending on OTC Pharmaceuticals market per capita in the region.
Furthermore, it is anticipated that 29.57% of the total revenue in the OTC Pharmaceuticals market will be generated through online sales by 2024.
This highlights the increasing importance of e-commerce in the industry.
The demand for OTC Pharmaceuticals in the Americas is driven by the growing health-consciousness among consumers.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Americas is witnessing significant growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the Americas region are increasingly opting for over-the-counter (OTC) pharmaceuticals due to their convenience and accessibility. OTC drugs are easily available without a prescription, allowing consumers to self-diagnose and treat common ailments such as cough, cold, and allergies. The preference for self-care and the desire to avoid long waiting times at healthcare facilities are driving the demand for OTC pharmaceuticals.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Americas is the growing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more sustainable. This has led to a surge in the popularity of herbal supplements, homeopathic remedies, and natural skincare products. Manufacturers are capitalizing on this trend by introducing a wide range of OTC products that cater to these preferences.Another trend in the market is the increasing adoption of online retail channels for purchasing OTC pharmaceuticals. E-commerce platforms provide consumers with a convenient and hassle-free shopping experience, allowing them to compare prices, read reviews, and make informed decisions. The COVID-19 pandemic has further accelerated this trend, as consumers are turning to online channels to avoid physical contact and reduce the risk of exposure to the virus.

Local special circumstances: The OTC Pharmaceuticals market in Americas is influenced by the unique healthcare systems and regulations in each country. In the United States, for example, the Food and Drug Administration (FDA) regulates the sale and marketing of OTC drugs, ensuring their safety and effectiveness. In Canada, the sale of OTC drugs is regulated by Health Canada, which sets standards for labeling and product information. These local regulations play a crucial role in shaping the market dynamics and consumer behavior.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Americas is also influenced by underlying macroeconomic factors such as population growth, disposable income, and healthcare expenditure. As the population continues to grow, the demand for OTC pharmaceuticals is expected to increase. Rising disposable income levels enable consumers to spend more on healthcare products, including OTC drugs. Additionally, governments in the region are increasing their healthcare expenditure, which is expected to drive the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Americas is experiencing significant growth due to customer preferences for convenience and accessibility, trends such as the demand for natural and herbal remedies, the adoption of online retail channels, local special circumstances such as healthcare regulations, and underlying macroeconomic factors including population growth, disposable income, and healthcare expenditure. These factors are expected to continue driving the growth of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.